PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAminocaproic acid
Aminocaproic acid
Aminocaproic Acid (aminocaproic acid) is a small molecule pharmaceutical. Aminocaproic acid was first approved as Amicar on 1982-01-01. The pharmaceutical is active against plasminogen.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Amicar (generic drugs available since 1987-03-09)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Aminocaproic acid
Tradename
Company
Number
Date
Products
AMICARAkornN-015197 RX1982-01-01
2 products, RLD
AMICARAkornN-015230 RX1982-01-01
1 products, RLD, RS
Show 2 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
28tak gum care toothunapproved drug other2018-07-17
amicarNew Drug Application2022-06-28
aminocaproic acidANDA2023-12-29
bamboo salt eunganggo jook yeomOTC monograph not final2011-03-16
bamboo salt eunganggo jook yeom toothpasteOTC monograph not final2010-06-21
clean breath toothunapproved drug other2021-11-30
dr.el gum care toothunapproved drug other2019-09-25
dr.lord green propol toothunapproved drug other2022-04-06
greensaltrain toothunapproved drug other2021-11-30
hae yan toothunapproved drug other2020-05-29
Show 11 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
B: Blood and blood forming organ drugs
— B02: Antihemorrhagics
— B02A: Antifibrinolytics
— B02AA: Antifibrinolytic amino acids
— B02AA01: Aminocaproic acid
HCPCS
Code
Description
S0017
Injection, aminocaproic acid, 5 grams
Clinical
Clinical Trials
36 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HemorrhageD006470MP_0001914R58——1113
FibrinolysisD005342———11113
OsteoarthritisD010003EFO_0002506M15-M19———123
ScoliosisD012600EFO_0004273M41———123
Oral hemorrhageD006472—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cardiopulmonary bypassD002315———11—12
InflammationD007249MP_0001845——11—12
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Knee osteoarthritisD020370EFO_0004616M17—1——12
CraniosynostosesD003398HP_0005458Q75.011———2
Surgical blood lossD016063———1———1
ThrombosisD013927———1———1
Hematologic neoplasmsD019337———1———1
ThrombocytopeniaD013921HP_0001873D69.6—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cerebral hemorrhageD002543——1————1
Aortic diseasesD001018——1————1
RosaceaD012393—L711————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart failureD006333HP_0001635I50————22
HypertensionD006973EFO_0000537I10————22
MenorrhagiaD008595EFO_0003945N92.0————22
Hemophilia aD006467EFO_0007267D66————22
PainD010146EFO_0003843R52————22
PneumoniaD011014EFO_0003106—————22
HyperaldosteronismD006929HP_0011736E26————22
Pulmonary arterial hypertensionD000081029——————22
Urinary tract infectionsD014552EFO_0003103N39.0————22
HypokalemiaD007008HP_0002900E87.6————22
Show 50 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAminocaproic acid
INNaminocaproic acid
Description
6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator. It has a role as an antifibrinolytic drug, a hematologic agent and a metabolite. It is an epsilon-amino acid and an omega-amino fatty acid. It is functionally related to a hexanoic acid. It is a conjugate acid of a 6-aminohexanoate. It is a tautomer of a 6-aminohexanoic acid zwitterion.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
NCCCCCC(=O)O
Identifiers
PDB—
CAS-ID60-32-2
RxCUI—
ChEMBL IDCHEMBL1046
ChEBI ID16586
PubChem CID564
DrugBankDB00513
UNII IDU6F3787206 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
LPA
LPA
Organism
Homo sapiens
Gene name
LPA
Gene synonyms
NCBI Gene ID
Protein name
apolipoprotein(a)
Protein synonyms
antiangiogenic AK38 protein, apo(a), lipoprotein, Lp(a), lp(a)
Uniprot ID
Mouse ortholog
—
—
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Aminocaproic acid
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,302 documents
View more details
Safety
Black-box Warning
Black-box warning for: Lisinopril
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
177 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use